| Bioactivity | vMIP-II (1-21) (NT21MP) TFA is an inhibitor of CXCR4. vMIP-II (1-21) TFA interacts broadly with CC and CXC chemokine receptors. vMIP-II (1-21) TFA inhibits CXCR4 by competing with 125I-SDF-1R for binding sites (IC50=190 nM)[1]. | ||||||
| Sequence | Leu-Gly-Ala-Ser-Trp-His-Arg-Pro-Asp-Lys-Cys-Cys-Leu-Gly-Tyr-Gln-Lys-Arg-Pro-Leu-Pro | ||||||
| Shortening | LGASWHRPDKCCLGYQKRPLP | ||||||
| Formula | C108H169N33O27S.xC2HF3O2 | ||||||
| Molar Mass | 2425.84 (free base) | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Zhou N, ey al. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II. Biochemistry. 2000 Apr 4;39(13):3782-7. |
vMIP-II (1-21) TFA
CAS: F: C108H169N33O27S.xC2HF3O2 W: 2425.84 (free base)
vMIP-II (1-21) (NT21MP) TFA is an inhibitor of CXCR4. vMIP-II (1-21) TFA interacts broadly with CC and CXC chemokine rec
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.